Rebalix
Logo AmundiAmundi · sheet of 10 September 2026
ETF sheet · official issuer and register data

Amundi ETF DAX UCITS ETF DR

CG1 · FR0010655712 · EUR · domicile France
Equity · GermanySFDR art. 6
Index tracked: DAX Net Retrun Index
TER
0.10%+ trans. 0.01%
Fund size
1.4 bn EUR
Tracking difference
+0.22%3-year avg
🇮🇹 tax rate
white list not published
Replication
Physical
Income
Mixed (acc. and/or dist.)
Launch 16 Sept 2008 · costs from the KID as of 2 Sept 2026 · 42 securities held · 10 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 4 Aug 2026
By subscribing to AMUNDI ETF DAX UCITS ETF DR, you are investing in a passively managed UCITS whose objective is to replicate as closely as possible the performance of the DAX NET RETURN (the "Index") regardless of whether it experiences a positive or negative development. The expected level of the tracking error under normal market conditions is indicated in the Fund prospectus. The equities included in the composition of the DAX Index are derived from the universe of the most important securities in the German market. This covers the top 40 market…

Performance since series start (in euro) — base 100

10 Jul 20178 Sept 2026 · dividends reinvested where declared by the issuer
2018202020222024202620568202
High 205 (14 Aug 2026) · low 68 (18 Mar 2020) · last 202. Past performance is not indicative of future results.

Returns in euro

1 year+9.7%
3 years+62.8%
5 years+60.0%
10 yearsseries too young
Since series start+101.8%

Risk · 1 / 3 / 5 years

Volatility (ann.)15.73%15.22%17.01%
Max drawdown−12.33%−16.02%−26.78%
Sharpe0.460.920.50
Sortino0.681.330.71
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · CG1 · FR00106557121
RebalixCG1 · FR0010655712 · sheet of 10 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · declared by the issuer
YearFundIndexTD
2025+22.46%+22.30%+0.16%
2024+18.24%+18.01%+0.23%
2023+19.62%+19.34%+0.28%
2022−12.87%−13.10%+0.23%
2021+15.33%+15.18%+0.16%

Holdings

Portfolio as declared by the issuer · 1 Sept 2026 · 42 securities · top-10 weight = 64.6%
Top holdingsWeight
SIEMENS AG-REG11.5%
SAP SE / XETRA10.5%
ALLIANZ SE-REG9.7%
AIRBUS SE-BERLIN6.5%
SIEMENS ENERGY AG6.5%
DEUTSCHE TELEKOM NAMEN (XETRA)5.5%
INFINEON TECHNOLOGIES AG4.1%
MUENCHENER RUECKVER AG-REG3.8%
DEUTSCHE BANK AG NAMEN3.7%
DEUTSCHE BOERSE AG3.0%
Countries (% of fund)
Germany100.0%
Sectors (% of fund)
Industrials34.1%Financials22.1%Information Technology14.6%Health Care6.5%Consumer Discretionary6.2%

Listing venues

ESMA register (FIRDS) and official exchange lists
CG1 · Borsa Italiana (ETFplus), Euronext Paris
· Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange
CG1GR · Xetra (Deutsche Börse)
+ 24 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.amundietf.it/pdfDocuments/kid-priips/FR0010655712/ENG/NLD
Factsheet · www.amundietf.it/pdfDocuments/monthly-factsheet/FR0010655712/ENG/GBR/I
Prospectus · www.amundietf.it/pdfDocuments/prospectus/FR0010655712/ENG/GBR
The live sheet, always up to date
rebalix.com/en/etf/FR0010655712
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · CG1 · FR00106557122